Shockwave Medical, Inc.
SWAVUnited States
22 filed reports · 396 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
22 reports · Mar 2019 to Mar 2024Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 16 | 2,571 | Mar 2019 to Mar 2024 |
| Annual · 10-KSEC EDGAR | 5 | 2,376 | Dec 2019 to Dec 2023 |
| Registration · S-1SEC EDGAR | 1 | 174 | Nov 2019 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2024 Q1 | 10-Q | 2024-03-31 | 2024-05-06 | 344 | Open |
| FY2023 | 10-K | 2023-12-31 | 2024-02-26 | 873 | Open |
| FY2023 Q3 | 10-Q | 2023-09-30 | 2023-11-06 | 267 | Open |
| FY2023 Q2 | 10-Q | 2023-06-30 | 2023-08-07 | 234 | Open |
| FY2023 Q1 | 10-Q | 2023-03-31 | 2023-05-08 | 134 | Open |
| FY2022 | 10-K | 2022-12-31 | 2023-02-27 | 415 | Open |
| FY2022 Q3 | 10-Q | 2022-09-30 | 2022-11-07 | 161 | Open |
| FY2022 Q2 | 10-Q | 2022-06-30 | 2022-08-08 | 131 | Open |
| FY2022 Q1 | 10-Q | 2022-03-31 | 2022-05-09 | 141 | Open |
| FY2021 | 10-K | 2021-12-31 | 2022-02-25 | 430 | Open |
| FY2021 Q3 | 10-Q | 2021-09-30 | 2021-11-08 | 162 | Open |
| FY2021 Q2 | 10-Q | 2021-06-30 | 2021-08-09 | 118 | Open |
Financial data
396 concepts · 5,121 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial393 concepts · 4,912 facts · Dec 2017 to Mar 2024
- Stockholders equity (US GAAP)33 · Dec 2017 to Mar 2024
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Dec 2017 to Mar 2024
- Capital expenditures incurred but not yet paid32 · Dec 2017 to Mar 2024
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations32 · Dec 2017 to Mar 2024
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect32 · Dec 2017 to Mar 2024
- Comprehensive income net of tax32 · Dec 2017 to Mar 2024
- Cost of goods and services sold (US GAAP)32 · Dec 2017 to Mar 2024
- Costs and expenses32 · Dec 2017 to Mar 2024
- General and administrative expense (US GAAP)32 · Dec 2017 to Mar 2024
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest32 · Dec 2017 to Mar 2024
- Income tax expense benefit32 · Dec 2017 to Mar 2024
- Increase decrease in accounts payable32 · Dec 2017 to Mar 2024
- Increase decrease in accounts receivable32 · Dec 2017 to Mar 2024
- Increase decrease in accrued liabilities and other operating liabilities32 · Dec 2017 to Mar 2024
- Increase decrease in inventories32 · Dec 2017 to Mar 2024
- Increase decrease in prepaid deferred expense and other assets32 · Dec 2017 to Mar 2024
- Interest expense (US GAAP)32 · Dec 2017 to Mar 2024
- Interest paid net32 · Dec 2017 to Mar 2024
- Net cash provided by used in financing activities32 · Dec 2017 to Mar 2024
- Net cash provided by used in investing activities32 · Dec 2017 to Mar 2024
- Net cash provided by used in operating activities32 · Dec 2017 to Mar 2024
- Net income loss32 · Dec 2017 to Mar 2024
- Operating income loss32 · Dec 2017 to Mar 2024
- Payments to acquire property plant and equipment32 · Dec 2017 to Mar 2024
Geography2 concepts · 123 facts · Dec 2017 to Mar 2024
- Revenue120 · Dec 2017 to Mar 2024
- Operating Lease Liability Weighted Average Incremental Borrowing Rate3 · Mar 2019 to Dec 2020
Product1 concept · 86 facts · Dec 2018 to Mar 2024
- Revenue86 · Dec 2018 to Mar 2024
Segments
209 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical5 members · 123 facts
- All Other Countries32 · Dec 2017 to Mar 2024
- United States32 · Dec 2017 to Mar 2024
- Europe22 · Dec 2019 to Mar 2024
- Germany20 · Dec 2017 to Mar 2021
- Rest of Europe17 · Dec 2017 to Mar 2021
Product or service5 members · 86 facts
- Other24 · Dec 2018 to Mar 2024
- Coronary23 · Dec 2018 to Mar 2024
- Peripheral23 · Dec 2018 to Mar 2024
- Reducer12 · Dec 2021 to Mar 2024
- License4 · Mar 2021 to Mar 2022
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of Shockwave Medical, Inc. (SWAV) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.